Preimplantation genetic screening: back to the future

Research output: Contribution to journalArticleAcademicpeer-review

98 Citations (Scopus)

Abstract

All agree that in hindsight the rapid adoption of preimplantation genetic screening (PGS) using cleavage stage biopsy and fluorescence in situ hybridization (FISH) in routine clinical practice without proper evaluation of (cost-)effectiveness basically resulted in couples paying more money for a less effective treatment. Now, almost 20 years later, we are on the verge of a new era of PGS. But have things really changed or are we simply going back to the future?
Original languageEnglish
Pages (from-to)1846-1850
JournalHuman reproduction (Oxford, England)
Volume29
Issue number9
DOIs
Publication statusPublished - 2014

Cite this